Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Symbollon Beginning Phase III With Product For Breast Pain

Dec. 23, 2004

By Jennifer Boggs

Symbollon Beginning Phase III With Product For Breast Pain

Dec. 23, 2004

By Jennifer Boggs

Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal

Dec. 22, 2004

By Jennifer Boggs

Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal

Dec. 22, 2004

By Jennifer Boggs

Gilead, BMS Establish JV To Combine HIV Products

Dec. 21, 2004

By Jennifer Boggs

Gilead, BMS Establish JV To Combine HIV Products

Dec. 21, 2004

By Jennifer Boggs

CancerVax Partners Canvaxin With Serono For Up To $290M

Dec. 17, 2004

By Jennifer Boggs

CancerVax Partners Canvaxin With Serono For Up To $290M

Dec. 17, 2004

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 13, 2025.
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
China’s NMPA gives thumbs up to Remegen’s ADC targeting HER2
BioWorld
China’s National Medical Products Administration has approved Remegen Co. Ltd.’s antibody-drug conjugate (ADC), disitamab vedotin (RC-48), for treatment of...